Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pulmonary Embolism | 24 | 2023 | 2370 | 3.680 |
Why?
|
Echocardiography | 29 | 2023 | 5097 | 2.480 |
Why?
|
Ventricular Dysfunction, Right | 6 | 2021 | 578 | 1.240 |
Why?
|
Guideline Adherence | 8 | 2020 | 2266 | 1.210 |
Why?
|
Hypertension, Pulmonary | 4 | 2022 | 1527 | 1.090 |
Why?
|
Pericarditis | 2 | 2020 | 128 | 1.040 |
Why?
|
Echocardiography, Transesophageal | 4 | 2019 | 1129 | 0.910 |
Why?
|
Critical Care | 7 | 2022 | 2640 | 0.850 |
Why?
|
Electrocardiography | 15 | 2020 | 6440 | 0.830 |
Why?
|
Thrombolytic Therapy | 3 | 2022 | 2161 | 0.800 |
Why?
|
Liability, Legal | 2 | 2019 | 213 | 0.800 |
Why?
|
Dyspnea | 8 | 2023 | 1298 | 0.800 |
Why?
|
Embolectomy | 2 | 2022 | 120 | 0.750 |
Why?
|
Tricuspid Valve | 3 | 2021 | 400 | 0.720 |
Why?
|
Patient Care Team | 6 | 2021 | 2527 | 0.700 |
Why?
|
Insurance, Liability | 1 | 2019 | 102 | 0.640 |
Why?
|
Organizational Innovation | 3 | 2020 | 559 | 0.610 |
Why?
|
Acute Disease | 12 | 2023 | 7141 | 0.600 |
Why?
|
Echocardiography, Four-Dimensional | 1 | 2016 | 16 | 0.590 |
Why?
|
Pericardial Effusion | 3 | 2015 | 246 | 0.580 |
Why?
|
Heart Valve Diseases | 3 | 2020 | 1067 | 0.580 |
Why?
|
Heart Neoplasms | 2 | 2016 | 374 | 0.550 |
Why?
|
Utilization Review | 2 | 2015 | 392 | 0.550 |
Why?
|
POEMS Syndrome | 1 | 2015 | 19 | 0.540 |
Why?
|
Pulmonary Heart Disease | 1 | 2015 | 36 | 0.530 |
Why?
|
Chagas Cardiomyopathy | 2 | 2010 | 72 | 0.530 |
Why?
|
Thrombectomy | 3 | 2017 | 679 | 0.530 |
Why?
|
Unnecessary Procedures | 2 | 2016 | 431 | 0.530 |
Why?
|
Endocarditis, Bacterial | 4 | 2022 | 453 | 0.520 |
Why?
|
Certification | 1 | 2017 | 423 | 0.480 |
Why?
|
Intra-Aortic Balloon Pumping | 1 | 2015 | 219 | 0.480 |
Why?
|
Polyneuropathies | 1 | 2015 | 139 | 0.470 |
Why?
|
Nitric Oxide Synthase Type III | 2 | 2007 | 689 | 0.460 |
Why?
|
Foramen Ovale, Patent | 1 | 2016 | 223 | 0.460 |
Why?
|
Intensive Care Units | 4 | 2024 | 3679 | 0.450 |
Why?
|
Foreign-Body Migration | 1 | 2015 | 221 | 0.450 |
Why?
|
Academic Medical Centers | 4 | 2019 | 2749 | 0.440 |
Why?
|
Laryngeal Neoplasms | 1 | 2016 | 512 | 0.440 |
Why?
|
Wounds, Gunshot | 1 | 2019 | 562 | 0.440 |
Why?
|
Endovascular Procedures | 2 | 2017 | 1973 | 0.430 |
Why?
|
Chest Pain | 7 | 2017 | 1113 | 0.430 |
Why?
|
Paraproteinemias | 1 | 2015 | 247 | 0.430 |
Why?
|
Ventricular Function, Left | 2 | 2022 | 3656 | 0.430 |
Why?
|
Respiratory Insufficiency | 2 | 2020 | 1199 | 0.430 |
Why?
|
Catheterization, Central Venous | 1 | 2016 | 514 | 0.410 |
Why?
|
Coronary Occlusion | 1 | 2015 | 303 | 0.410 |
Why?
|
Embolism | 1 | 2015 | 409 | 0.400 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2014 | 475 | 0.400 |
Why?
|
Drugs, Generic | 2 | 2008 | 422 | 0.400 |
Why?
|
Heart Function Tests | 1 | 2012 | 330 | 0.390 |
Why?
|
Diagnosis, Differential | 18 | 2023 | 12958 | 0.360 |
Why?
|
Humans | 98 | 2024 | 742088 | 0.360 |
Why?
|
Polyarteritis Nodosa | 1 | 2010 | 66 | 0.360 |
Why?
|
Drug Approval | 2 | 2008 | 740 | 0.360 |
Why?
|
Atrial Flutter | 1 | 2012 | 264 | 0.350 |
Why?
|
Aortic Diseases | 1 | 2015 | 741 | 0.350 |
Why?
|
Radiography, Interventional | 1 | 2017 | 1095 | 0.350 |
Why?
|
Aorta, Thoracic | 1 | 2015 | 1080 | 0.340 |
Why?
|
Heart Failure | 9 | 2023 | 10856 | 0.340 |
Why?
|
Coronary Artery Bypass | 3 | 2018 | 2281 | 0.330 |
Why?
|
Third-Party Consent | 2 | 2019 | 64 | 0.310 |
Why?
|
Mitral Valve Insufficiency | 2 | 2014 | 1415 | 0.310 |
Why?
|
Tachycardia, Ventricular | 1 | 2016 | 1272 | 0.310 |
Why?
|
Shock, Cardiogenic | 2 | 2024 | 684 | 0.310 |
Why?
|
Myocardial Infarction | 4 | 2021 | 11690 | 0.310 |
Why?
|
Endocarditis | 2 | 2022 | 348 | 0.300 |
Why?
|
Pericardium | 1 | 2012 | 667 | 0.300 |
Why?
|
Heart Defects, Congenital | 3 | 2019 | 4566 | 0.290 |
Why?
|
Disease Management | 3 | 2019 | 2450 | 0.290 |
Why?
|
Fibrinolytic Agents | 1 | 2017 | 2156 | 0.290 |
Why?
|
Mental Competency | 2 | 2019 | 176 | 0.290 |
Why?
|
Defibrillators, Implantable | 2 | 2019 | 1440 | 0.290 |
Why?
|
Heart Diseases | 5 | 2022 | 2789 | 0.290 |
Why?
|
Legislation, Drug | 2 | 2008 | 206 | 0.290 |
Why?
|
Recombinant Proteins | 2 | 2008 | 6608 | 0.280 |
Why?
|
Head and Neck Neoplasms | 2 | 2019 | 2712 | 0.280 |
Why?
|
Male | 49 | 2024 | 349538 | 0.280 |
Why?
|
Exercise Test | 3 | 2022 | 2075 | 0.280 |
Why?
|
Heart | 3 | 2018 | 4462 | 0.270 |
Why?
|
Ventricular Function, Right | 3 | 2021 | 592 | 0.270 |
Why?
|
Coronary Stenosis | 1 | 2012 | 834 | 0.270 |
Why?
|
Cardiology | 5 | 2022 | 1658 | 0.260 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3130 | 0.260 |
Why?
|
State Government | 2 | 2019 | 369 | 0.260 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3236 | 0.260 |
Why?
|
Heart-Assist Devices | 1 | 2015 | 1194 | 0.260 |
Why?
|
Quality Improvement | 3 | 2016 | 3738 | 0.250 |
Why?
|
Coronary Vessels | 2 | 2018 | 3099 | 0.240 |
Why?
|
Acute Coronary Syndrome | 2 | 2015 | 2337 | 0.240 |
Why?
|
Substance Abuse, Intravenous | 2 | 2022 | 522 | 0.240 |
Why?
|
Myocardial Ischemia | 1 | 2014 | 2145 | 0.230 |
Why?
|
Heart Ventricles | 5 | 2023 | 3801 | 0.230 |
Why?
|
Critical Illness | 3 | 2021 | 2665 | 0.230 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2014 | 2059 | 0.230 |
Why?
|
Lung | 7 | 2023 | 9826 | 0.230 |
Why?
|
Health Resources | 2 | 2019 | 911 | 0.230 |
Why?
|
Disease Progression | 3 | 2023 | 13256 | 0.220 |
Why?
|
Cardiomyopathies | 1 | 2015 | 1912 | 0.220 |
Why?
|
Cardiac Imaging Techniques | 2 | 2015 | 269 | 0.210 |
Why?
|
Pulmonary Artery | 3 | 2022 | 1911 | 0.210 |
Why?
|
Nitric Oxide | 3 | 2007 | 2128 | 0.210 |
Why?
|
Radiography, Thoracic | 4 | 2019 | 1265 | 0.210 |
Why?
|
Decision Making | 4 | 2020 | 3869 | 0.210 |
Why?
|
Risk Assessment | 6 | 2019 | 23320 | 0.200 |
Why?
|
Emergency Service, Hospital | 3 | 2017 | 7645 | 0.200 |
Why?
|
Advance Directives | 2 | 2020 | 245 | 0.200 |
Why?
|
Tobacco Industry | 1 | 2003 | 126 | 0.200 |
Why?
|
Identity Crisis | 1 | 2001 | 12 | 0.200 |
Why?
|
Coronary Angiography | 4 | 2020 | 4567 | 0.200 |
Why?
|
Edema | 2 | 2022 | 790 | 0.190 |
Why?
|
Mind-Body Relations, Metaphysical | 1 | 2001 | 38 | 0.190 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2016 | 4029 | 0.190 |
Why?
|
Aged | 21 | 2022 | 162944 | 0.190 |
Why?
|
Ehlers-Danlos Syndrome | 1 | 2021 | 89 | 0.190 |
Why?
|
Physicians | 1 | 2019 | 4554 | 0.190 |
Why?
|
Drug Users | 1 | 2022 | 131 | 0.190 |
Why?
|
Tomography, X-Ray Computed | 8 | 2020 | 20086 | 0.180 |
Why?
|
Government Regulation | 2 | 2019 | 522 | 0.180 |
Why?
|
Stroke Volume | 3 | 2022 | 4983 | 0.180 |
Why?
|
Drug Dosage Calculations | 1 | 2020 | 113 | 0.180 |
Why?
|
Teaching Rounds | 1 | 2024 | 253 | 0.180 |
Why?
|
Lung Diseases, Parasitic | 1 | 2019 | 14 | 0.180 |
Why?
|
Furosemide | 1 | 2020 | 167 | 0.180 |
Why?
|
Proxy | 1 | 2020 | 144 | 0.180 |
Why?
|
Chronic Disease | 4 | 2022 | 9144 | 0.170 |
Why?
|
Privacy | 1 | 2002 | 237 | 0.170 |
Why?
|
Quadriplegia | 1 | 2001 | 225 | 0.170 |
Why?
|
Pulmonary Eosinophilia | 1 | 2019 | 82 | 0.160 |
Why?
|
Neck | 2 | 2022 | 693 | 0.160 |
Why?
|
Amiodarone | 1 | 2010 | 212 | 0.160 |
Why?
|
Ontario | 4 | 2019 | 381 | 0.160 |
Why?
|
Echocardiography, Doppler | 2 | 2019 | 934 | 0.160 |
Why?
|
Ventricular Pressure | 1 | 2019 | 199 | 0.160 |
Why?
|
Exanthema | 1 | 2022 | 488 | 0.160 |
Why?
|
Cardiology Service, Hospital | 1 | 2020 | 246 | 0.160 |
Why?
|
Syncope | 2 | 2018 | 429 | 0.150 |
Why?
|
Risk Adjustment | 1 | 2021 | 594 | 0.150 |
Why?
|
Diuretics | 1 | 2020 | 591 | 0.150 |
Why?
|
Female | 30 | 2024 | 379592 | 0.150 |
Why?
|
Dextrocardia | 1 | 2016 | 37 | 0.140 |
Why?
|
Cholecystitis | 1 | 2017 | 182 | 0.140 |
Why?
|
Teratoma | 1 | 2019 | 387 | 0.140 |
Why?
|
Cardiac Output | 1 | 2019 | 853 | 0.140 |
Why?
|
Middle Aged | 22 | 2022 | 213127 | 0.140 |
Why?
|
Flank Pain | 2 | 2010 | 43 | 0.140 |
Why?
|
Causality | 1 | 2003 | 1265 | 0.140 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2018 | 434 | 0.140 |
Why?
|
Pericardiocentesis | 2 | 2015 | 74 | 0.140 |
Why?
|
Cholelithiasis | 1 | 2017 | 411 | 0.140 |
Why?
|
Gallbladder | 1 | 2017 | 301 | 0.140 |
Why?
|
Heart Aneurysm | 2 | 2010 | 120 | 0.130 |
Why?
|
Hospitals, Proprietary | 1 | 2015 | 39 | 0.130 |
Why?
|
Still's Disease, Adult-Onset | 1 | 2015 | 19 | 0.130 |
Why?
|
Coronary Aneurysm | 1 | 2018 | 237 | 0.130 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2010 | 790 | 0.130 |
Why?
|
Pica | 1 | 2015 | 32 | 0.130 |
Why?
|
Drug Industry | 1 | 2002 | 744 | 0.130 |
Why?
|
Hemothorax | 1 | 2015 | 59 | 0.130 |
Why?
|
Prognosis | 7 | 2023 | 29010 | 0.130 |
Why?
|
Exercise Tolerance | 2 | 2018 | 770 | 0.130 |
Why?
|
Retrospective Studies | 11 | 2022 | 77098 | 0.130 |
Why?
|
Saphenous Vein | 1 | 2018 | 531 | 0.130 |
Why?
|
Troponin T | 1 | 2020 | 749 | 0.130 |
Why?
|
Hypereosinophilic Syndrome | 1 | 2015 | 93 | 0.130 |
Why?
|
Enzyme Inhibitors | 1 | 2006 | 3800 | 0.120 |
Why?
|
Self Concept | 1 | 2001 | 1025 | 0.120 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 740 | 0.120 |
Why?
|
Withholding Treatment | 1 | 2019 | 598 | 0.120 |
Why?
|
Endothelium, Vascular | 1 | 2007 | 4455 | 0.120 |
Why?
|
Bundle-Branch Block | 1 | 2016 | 270 | 0.120 |
Why?
|
Postoperative Complications | 2 | 2021 | 15244 | 0.120 |
Why?
|
Practice Guidelines as Topic | 4 | 2019 | 7276 | 0.120 |
Why?
|
Early Diagnosis | 2 | 2019 | 1184 | 0.120 |
Why?
|
Patient Transfer | 1 | 2021 | 760 | 0.120 |
Why?
|
Pregnant Women | 1 | 2019 | 566 | 0.120 |
Why?
|
Vena Cava Filters | 1 | 2017 | 252 | 0.120 |
Why?
|
Heroin Dependence | 1 | 2014 | 175 | 0.120 |
Why?
|
Adult | 20 | 2020 | 213712 | 0.120 |
Why?
|
Testicular Neoplasms | 2 | 2019 | 761 | 0.110 |
Why?
|
Cardiovascular Diseases | 3 | 2019 | 15108 | 0.110 |
Why?
|
Bioprosthesis | 1 | 2018 | 596 | 0.110 |
Why?
|
Electric Countershock | 2 | 2018 | 535 | 0.110 |
Why?
|
Patient Selection | 2 | 2017 | 4214 | 0.110 |
Why?
|
Stents | 2 | 2015 | 3276 | 0.110 |
Why?
|
Predictive Value of Tests | 6 | 2019 | 15056 | 0.110 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2010 | 1517 | 0.110 |
Why?
|
Prosthesis-Related Infections | 1 | 2019 | 538 | 0.110 |
Why?
|
Ownership | 1 | 2015 | 331 | 0.110 |
Why?
|
Aortic Valve | 2 | 2020 | 1911 | 0.110 |
Why?
|
Equipment Failure Analysis | 1 | 2015 | 867 | 0.110 |
Why?
|
Treatment Outcome | 6 | 2022 | 62966 | 0.110 |
Why?
|
Aortic Rupture | 1 | 2015 | 310 | 0.110 |
Why?
|
Pneumopericardium | 1 | 2012 | 6 | 0.110 |
Why?
|
History, 20th Century | 3 | 2008 | 2739 | 0.110 |
Why?
|
Postpericardiotomy Syndrome | 1 | 2012 | 12 | 0.110 |
Why?
|
Ventricular Fibrillation | 1 | 2015 | 538 | 0.110 |
Why?
|
Back Pain | 1 | 2016 | 545 | 0.100 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2019 | 687 | 0.100 |
Why?
|
Sensitivity and Specificity | 3 | 2017 | 14720 | 0.100 |
Why?
|
Graft Occlusion, Vascular | 1 | 2015 | 548 | 0.100 |
Why?
|
Pericardiectomy | 1 | 2012 | 45 | 0.100 |
Why?
|
Massachusetts | 4 | 2021 | 8662 | 0.100 |
Why?
|
Patient Positioning | 1 | 2014 | 322 | 0.100 |
Why?
|
Fatal Outcome | 1 | 2016 | 1849 | 0.100 |
Why?
|
Mitral Valve Stenosis | 1 | 2014 | 376 | 0.100 |
Why?
|
Oximetry | 1 | 2014 | 467 | 0.100 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2015 | 364 | 0.100 |
Why?
|
Cardiac Tamponade | 1 | 2012 | 173 | 0.100 |
Why?
|
Pulmonary Emphysema | 1 | 2016 | 672 | 0.100 |
Why?
|
Registries | 3 | 2021 | 8077 | 0.090 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2016 | 484 | 0.090 |
Why?
|
Surgical Procedures, Operative | 1 | 2022 | 1873 | 0.090 |
Why?
|
Blood Vessel Prosthesis | 1 | 2015 | 933 | 0.090 |
Why?
|
Antihypertensive Agents | 2 | 2021 | 2043 | 0.090 |
Why?
|
Blood Coagulation | 1 | 2016 | 1126 | 0.090 |
Why?
|
Heart Valve Prosthesis | 1 | 2019 | 1486 | 0.090 |
Why?
|
Delivery of Health Care | 2 | 2020 | 5304 | 0.090 |
Why?
|
Pandemics | 2 | 2020 | 8328 | 0.090 |
Why?
|
Suicide, Attempted | 1 | 2018 | 1218 | 0.090 |
Why?
|
Prosthesis Failure | 1 | 2015 | 1203 | 0.090 |
Why?
|
Staphylococcal Infections | 1 | 2019 | 1398 | 0.090 |
Why?
|
Education, Medical, Graduate | 1 | 2022 | 2283 | 0.090 |
Why?
|
Mastocytosis, Systemic | 1 | 2011 | 100 | 0.090 |
Why?
|
Reproducibility of Results | 3 | 2019 | 19862 | 0.090 |
Why?
|
Abdominal Pain | 2 | 2010 | 1059 | 0.090 |
Why?
|
Internet | 1 | 2002 | 3062 | 0.090 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2015 | 685 | 0.080 |
Why?
|
Neck Pain | 2 | 2021 | 179 | 0.080 |
Why?
|
Magnetic Resonance Angiography | 1 | 2015 | 1440 | 0.080 |
Why?
|
Outpatients | 1 | 2016 | 1483 | 0.080 |
Why?
|
Curriculum | 1 | 2022 | 3589 | 0.080 |
Why?
|
United States Food and Drug Administration | 2 | 2008 | 1581 | 0.080 |
Why?
|
Risk Factors | 6 | 2022 | 72145 | 0.080 |
Why?
|
Prospective Studies | 6 | 2021 | 53187 | 0.080 |
Why?
|
Models, Cardiovascular | 1 | 2013 | 994 | 0.080 |
Why?
|
Clinical Competence | 2 | 2022 | 4681 | 0.080 |
Why?
|
Heart Arrest | 1 | 2018 | 1469 | 0.080 |
Why?
|
United States | 9 | 2019 | 69693 | 0.080 |
Why?
|
Substance-Related Disorders | 2 | 2021 | 4250 | 0.080 |
Why?
|
Perioperative Care | 1 | 2015 | 997 | 0.080 |
Why?
|
Nitrosation | 1 | 2007 | 26 | 0.080 |
Why?
|
Antibodies, Monoclonal | 1 | 2005 | 9274 | 0.080 |
Why?
|
Biological Products | 2 | 2008 | 856 | 0.070 |
Why?
|
Risk | 2 | 2017 | 9679 | 0.070 |
Why?
|
Venous Thromboembolism | 1 | 2020 | 1668 | 0.070 |
Why?
|
Patents as Topic | 1 | 2008 | 103 | 0.070 |
Why?
|
Follow-Up Studies | 4 | 2021 | 39004 | 0.070 |
Why?
|
Pollen | 1 | 2006 | 75 | 0.070 |
Why?
|
Mental Health | 1 | 2020 | 2997 | 0.070 |
Why?
|
Zea mays | 1 | 2006 | 105 | 0.070 |
Why?
|
Thrombosis | 1 | 2020 | 2966 | 0.070 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2015 | 1384 | 0.070 |
Why?
|
Mitral Valve | 1 | 2014 | 1484 | 0.070 |
Why?
|
Aortic Valve Stenosis | 1 | 2018 | 1941 | 0.070 |
Why?
|
Blood Pressure | 1 | 2021 | 8541 | 0.060 |
Why?
|
Decision Support Techniques | 1 | 2014 | 1952 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2019 | 3151 | 0.060 |
Why?
|
Plant Proteins | 1 | 2006 | 364 | 0.060 |
Why?
|
Consumer Product Safety | 1 | 2005 | 122 | 0.060 |
Why?
|
Acetylation | 1 | 2007 | 1085 | 0.060 |
Why?
|
Signal Transduction | 1 | 2007 | 23387 | 0.060 |
Why?
|
Image Enhancement | 1 | 2014 | 2921 | 0.060 |
Why?
|
Length of Stay | 1 | 2017 | 6294 | 0.060 |
Why?
|
Anticoagulants | 2 | 2016 | 4595 | 0.060 |
Why?
|
Radiology | 2 | 2016 | 2090 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 5 | 2021 | 35342 | 0.060 |
Why?
|
Biotechnology | 1 | 2005 | 278 | 0.050 |
Why?
|
Hospitalization | 3 | 2020 | 10232 | 0.050 |
Why?
|
Smoking | 1 | 2019 | 8969 | 0.050 |
Why?
|
Fraud | 1 | 2003 | 67 | 0.050 |
Why?
|
Blood | 1 | 2005 | 598 | 0.050 |
Why?
|
History, 19th Century | 1 | 2005 | 720 | 0.050 |
Why?
|
Health Care Costs | 1 | 2015 | 3203 | 0.050 |
Why?
|
Oxygen Consumption | 3 | 2018 | 1869 | 0.050 |
Why?
|
Civil Rights | 1 | 2003 | 132 | 0.050 |
Why?
|
Collagen Type III | 1 | 2021 | 90 | 0.050 |
Why?
|
Atrial Fibrillation | 1 | 2020 | 5019 | 0.050 |
Why?
|
Information Management | 1 | 2002 | 98 | 0.050 |
Why?
|
Pregnancy Complications | 1 | 2015 | 2861 | 0.050 |
Why?
|
Headache | 2 | 2021 | 1219 | 0.050 |
Why?
|
Isoenzymes | 1 | 2006 | 1725 | 0.050 |
Why?
|
Systole | 1 | 2023 | 956 | 0.050 |
Why?
|
Ego | 1 | 2001 | 96 | 0.050 |
Why?
|
Freedom | 1 | 2001 | 69 | 0.050 |
Why?
|
Diastole | 1 | 2023 | 791 | 0.050 |
Why?
|
Luminescence | 1 | 2001 | 137 | 0.050 |
Why?
|
Hospitals, General | 2 | 2016 | 749 | 0.050 |
Why?
|
District of Columbia | 1 | 2020 | 157 | 0.050 |
Why?
|
Bone Marrow | 1 | 2011 | 2941 | 0.050 |
Why?
|
Pain | 1 | 2015 | 4961 | 0.050 |
Why?
|
Quality of Health Care | 1 | 2015 | 4369 | 0.040 |
Why?
|
Professional-Family Relations | 1 | 2024 | 481 | 0.040 |
Why?
|
Marketing | 1 | 2002 | 208 | 0.040 |
Why?
|
Coronary Artery Disease | 1 | 2019 | 6454 | 0.040 |
Why?
|
Famous Persons | 1 | 2001 | 108 | 0.040 |
Why?
|
Medicare | 1 | 2017 | 6532 | 0.040 |
Why?
|
France | 1 | 2001 | 517 | 0.040 |
Why?
|
Elephantiasis, Filarial | 1 | 2019 | 29 | 0.040 |
Why?
|
Allergens | 1 | 2006 | 1314 | 0.040 |
Why?
|
Drug Therapy, Combination | 2 | 2019 | 6483 | 0.040 |
Why?
|
Cardiomyopathy, Hypertrophic, Familial | 1 | 2019 | 66 | 0.040 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2019 | 187 | 0.040 |
Why?
|
Protein Processing, Post-Translational | 1 | 2007 | 1989 | 0.040 |
Why?
|
History, 21st Century | 1 | 2005 | 1533 | 0.040 |
Why?
|
Lung Diseases, Fungal | 1 | 2019 | 122 | 0.040 |
Why?
|
Civil Defense | 1 | 2020 | 109 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2022 | 13019 | 0.040 |
Why?
|
Immunohistochemistry | 1 | 2012 | 11363 | 0.040 |
Why?
|
Sodium Bicarbonate | 1 | 2018 | 62 | 0.040 |
Why?
|
Health Services Accessibility | 1 | 2015 | 5133 | 0.040 |
Why?
|
Radiography | 3 | 2014 | 7010 | 0.040 |
Why?
|
Organizational Objectives | 1 | 2020 | 438 | 0.040 |
Why?
|
Longitudinal Studies | 3 | 2020 | 13921 | 0.040 |
Why?
|
Patient Care Management | 1 | 2021 | 306 | 0.040 |
Why?
|
Hypertrophy, Right Ventricular | 1 | 2018 | 110 | 0.040 |
Why?
|
Antidotes | 1 | 2018 | 138 | 0.040 |
Why?
|
Postoperative Period | 1 | 2022 | 1839 | 0.040 |
Why?
|
Fever | 2 | 2015 | 1612 | 0.040 |
Why?
|
Cross-Sectional Studies | 1 | 2017 | 24913 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2019 | 57683 | 0.030 |
Why?
|
Cerebral Infarction | 1 | 2021 | 1007 | 0.030 |
Why?
|
Bradycardia | 1 | 2018 | 305 | 0.030 |
Why?
|
Steroids | 1 | 2021 | 931 | 0.030 |
Why?
|
Evidence-Based Practice | 1 | 2020 | 500 | 0.030 |
Why?
|
Toxocariasis | 1 | 2015 | 11 | 0.030 |
Why?
|
Catheterization, Swan-Ganz | 1 | 2016 | 86 | 0.030 |
Why?
|
Phosphorylation | 1 | 2007 | 8436 | 0.030 |
Why?
|
Cough | 1 | 2019 | 555 | 0.030 |
Why?
|
Hypertension | 1 | 2015 | 8455 | 0.030 |
Why?
|
Hypotension, Orthostatic | 1 | 2018 | 255 | 0.030 |
Why?
|
Ultrasonography | 2 | 2019 | 5978 | 0.030 |
Why?
|
Eosinophilia | 1 | 2019 | 531 | 0.030 |
Why?
|
Watchful Waiting | 1 | 2019 | 491 | 0.030 |
Why?
|
Databases, Factual | 2 | 2020 | 7716 | 0.030 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2005 | 1348 | 0.030 |
Why?
|
Drug Synergism | 1 | 2019 | 1791 | 0.030 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2006 | 3617 | 0.030 |
Why?
|
Pulmonary Medicine | 1 | 2016 | 213 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2022 | 1071 | 0.030 |
Why?
|
Pharyngitis | 1 | 2015 | 215 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2016 | 13655 | 0.030 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2014 | 364 | 0.030 |
Why?
|
Aftercare | 1 | 2019 | 860 | 0.030 |
Why?
|
Hematology | 1 | 2016 | 219 | 0.030 |
Why?
|
Family | 1 | 2024 | 3144 | 0.030 |
Why?
|
Stroke | 1 | 2015 | 9963 | 0.030 |
Why?
|
Ferritins | 1 | 2015 | 590 | 0.030 |
Why?
|
Postoperative Hemorrhage | 1 | 2016 | 409 | 0.030 |
Why?
|
New York | 1 | 2014 | 886 | 0.030 |
Why?
|
Time Factors | 3 | 2019 | 40054 | 0.020 |
Why?
|
Fetus | 1 | 2019 | 1879 | 0.020 |
Why?
|
Endocrine Gland Neoplasms | 1 | 2011 | 25 | 0.020 |
Why?
|
Boston | 2 | 2014 | 9305 | 0.020 |
Why?
|
Flushing | 1 | 2011 | 49 | 0.020 |
Why?
|
Young Adult | 4 | 2023 | 56350 | 0.020 |
Why?
|
Canada | 1 | 2015 | 2061 | 0.020 |
Why?
|
Animals | 5 | 2019 | 168561 | 0.020 |
Why?
|
Communication | 1 | 2024 | 3728 | 0.020 |
Why?
|
Echocardiography, Three-Dimensional | 1 | 2015 | 591 | 0.020 |
Why?
|
Periodicals as Topic | 1 | 2001 | 1431 | 0.020 |
Why?
|
Consensus | 1 | 2019 | 2935 | 0.020 |
Why?
|
Ribs | 1 | 2011 | 250 | 0.020 |
Why?
|
Thoracic Surgery | 1 | 2016 | 713 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2019 | 1831 | 0.020 |
Why?
|
Brain | 1 | 2015 | 26343 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2016 | 15530 | 0.020 |
Why?
|
Proteomics | 1 | 2021 | 3618 | 0.020 |
Why?
|
Vision Disorders | 1 | 2015 | 1057 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2015 | 1402 | 0.020 |
Why?
|
Recovery of Function | 1 | 2018 | 2924 | 0.020 |
Why?
|
Heparin | 1 | 2014 | 1636 | 0.020 |
Why?
|
Alcoholism | 1 | 2017 | 1904 | 0.020 |
Why?
|
Emergency Medicine | 1 | 2016 | 1205 | 0.020 |
Why?
|
Thoracic Vertebrae | 1 | 2011 | 604 | 0.020 |
Why?
|
Disposable Equipment | 1 | 2005 | 43 | 0.020 |
Why?
|
Pregnancy | 2 | 2019 | 29087 | 0.020 |
Why?
|
Hydrolysis | 1 | 2006 | 682 | 0.020 |
Why?
|
Logistic Models | 1 | 2020 | 13403 | 0.020 |
Why?
|
Venous Thrombosis | 1 | 2014 | 1237 | 0.020 |
Why?
|
Hypotension | 1 | 2011 | 880 | 0.020 |
Why?
|
Health Status | 1 | 2018 | 4030 | 0.020 |
Why?
|
Hepatitis C | 1 | 2014 | 1582 | 0.020 |
Why?
|
Hemorrhage | 1 | 2016 | 3461 | 0.010 |
Why?
|
Anaphylaxis | 1 | 2011 | 746 | 0.010 |
Why?
|
Military Medicine | 1 | 2005 | 176 | 0.010 |
Why?
|
Cell Wall | 1 | 2006 | 422 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 9185 | 0.010 |
Why?
|
Protein Structure, Secondary | 1 | 2006 | 1245 | 0.010 |
Why?
|
Incidence | 1 | 2021 | 20928 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2015 | 3391 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6534 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 9941 | 0.010 |
Why?
|
Medicaid | 1 | 2015 | 2716 | 0.010 |
Why?
|
Contrast Media | 1 | 2015 | 5295 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2006 | 2257 | 0.010 |
Why?
|
Firefly Luciferin | 1 | 2001 | 10 | 0.010 |
Why?
|
NADPH Dehydrogenase | 1 | 2001 | 45 | 0.010 |
Why?
|
Octopamine | 1 | 2001 | 40 | 0.010 |
Why?
|
Crystallography, X-Ray | 1 | 2006 | 2014 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2015 | 5310 | 0.010 |
Why?
|
Patient Readmission | 1 | 2015 | 3111 | 0.010 |
Why?
|
Nitric Oxide Donors | 1 | 2001 | 121 | 0.010 |
Why?
|
Heart Transplantation | 1 | 2014 | 3119 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2014 | 3215 | 0.010 |
Why?
|
Peroxisomes | 1 | 2001 | 58 | 0.010 |
Why?
|
Sexual Behavior, Animal | 1 | 2001 | 113 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2019 | 7153 | 0.010 |
Why?
|
NADP | 1 | 2001 | 225 | 0.010 |
Why?
|
Costs and Cost Analysis | 1 | 2005 | 1679 | 0.010 |
Why?
|
Polysaccharides | 1 | 2006 | 1051 | 0.010 |
Why?
|
Benzoates | 1 | 2001 | 217 | 0.010 |
Why?
|
Cattle | 1 | 2005 | 3923 | 0.010 |
Why?
|
Luciferases | 1 | 2001 | 733 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2006 | 3847 | 0.010 |
Why?
|
Nitric Oxide Synthase | 1 | 2001 | 916 | 0.010 |
Why?
|
Age Factors | 1 | 2014 | 18355 | 0.010 |
Why?
|
Binding Sites | 1 | 2006 | 6115 | 0.010 |
Why?
|
Equipment Design | 1 | 2005 | 3582 | 0.010 |
Why?
|
Mutation | 1 | 2021 | 29717 | 0.010 |
Why?
|
Prevalence | 1 | 2014 | 15194 | 0.010 |
Why?
|
Quality of Life | 1 | 2018 | 12730 | 0.010 |
Why?
|
Models, Molecular | 1 | 2006 | 5454 | 0.010 |
Why?
|
Imidazoles | 1 | 2001 | 1205 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2006 | 13814 | 0.010 |
Why?
|
Protein Binding | 1 | 2006 | 9387 | 0.010 |
Why?
|
Cell Communication | 1 | 2001 | 1619 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2006 | 18112 | 0.010 |
Why?
|
Wounds and Injuries | 1 | 2005 | 2400 | 0.010 |
Why?
|
Motor Activity | 1 | 2001 | 2714 | 0.010 |
Why?
|
Oxygen | 1 | 2001 | 4169 | 0.010 |
Why?
|
Mitochondria | 1 | 2001 | 3520 | 0.000 |
Why?
|
Adolescent | 1 | 2013 | 85649 | 0.000 |
Why?
|